Abir Ali

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Elvebakken, Hege; Perren, Aurel; Scoazec, Jean-Yves; Tang, Laura H. et al.

Part of Neuroendocrinology, p. 883-894, 2021

• DOI for A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Perren, Aurel; Lindskog, Cecilia; Welin, Staffan et al.

Part of Scientific Reports, 2020

• DOI for Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
• Download full text (pdf) of Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav et al.

Part of PLOS ONE, 2020

• DOI for PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
• Download full text (pdf) of PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Gastroenteropancreatic Neuroendocrine Neoplasms Grade 3: Biological and Clinical Aspects

Ali, Abir Salwa

2019

• Download full text (pdf) of Gastroenteropancreatic Neuroendocrine Neoplasms Grade 3: Biological and Clinical Aspects

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Ali, Abir Salwa; Grönberg, Malin; Langer, Seppo W.; Ladekarl, Morten et al.

Part of Medical Oncology, 2018

• DOI for Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
• Download full text (pdf) of Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Elvebakken, Hege; Perren, Aurel; Scoazec, Jean-Yves; Tang, Laura H. et al.

Part of Neuroendocrinology, p. 883-894, 2021

• DOI for A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Perren, Aurel; Lindskog, Cecilia; Welin, Staffan et al.

Part of Scientific Reports, 2020

• DOI for Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
• Download full text (pdf) of Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav et al.

Part of PLOS ONE, 2020

• DOI for PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
• Download full text (pdf) of PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Ali, Abir Salwa; Grönberg, Malin; Langer, Seppo W.; Ladekarl, Morten et al.

Part of Medical Oncology, 2018

• DOI for Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
• Download full text (pdf) of Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Ali, Abir A.; Grönberg, Malin; Hjortland, G. O.; Grønbæk, H. et al.

Part of Neuroendocrinology, p. 184-184, 2018

• DOI for Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

Ali, Abir Salwa; Grönberg, Malin; Federspiel, Birgitte; Scoazec, Jean-Yves et al.

Part of PLOS ONE, 2017

• DOI for Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
• Download full text (pdf) of Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

Dumanski, Jan P.; Rasi, Chiara; Björklund, Peyman; Davies, Hanna et al.

Part of Endocrine-Related Cancer, p. 427-443, 2017

• DOI for A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
• Download full text (pdf) of A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3)

Ali, Abir; Grönberg, Malin; Federspiel, B.; Hjortland, G. O. et al.

Part of Neuroendocrinology, p. 43-43, 2016

Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours

Söderquist, Fanny; Tiensuu Janson, Eva; Rasmusson, Annica; Alit, Abir et al.

Part of PLOS ONE, 2016

• DOI for Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours
• Download full text (pdf) of Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours

Gastroenteropancreatic Neuroendocrine Neoplasms Grade 3: Biological and Clinical Aspects

Ali, Abir Salwa

2019

• Download full text (pdf) of Gastroenteropancreatic Neuroendocrine Neoplasms Grade 3: Biological and Clinical Aspects